Suppr超能文献

CCR5Δ32 突变在克里米亚-刚果出血热感染中的可能作用。

The possible role of CCR5Δ32 mutation in Crimean-Congo hemorrhagic fever infection.

机构信息

Faculty of Medicine, Gaziosmanpasa University, Department of Medical Biology, Tokat, Turkey.

Faculty of Medicine, Hitit University, Department of Medical Genetics, Çorum, Turkey.

出版信息

J Med Virol. 2017 Oct;89(10):1714-1719. doi: 10.1002/jmv.24865. Epub 2017 Jul 6.

Abstract

Crimean-Congo hemorrhagic fever infection (CCHF) is a viral zoonosis. The pathogenesis of this disease has not been established so far, however, cytokines account for its progression and outcome. The aim of the present study is to investigate the association between chemokine receptor 5 (CCR5) gene Δ32 mutation and pathogenity, severity, and mortality of CCHF. This case-control study included 133 CCHF patients diagnosed by detection of CCHV RNA positivity and 97 healthy control subjects. CCR5 gene Δ32 mutation analyzed by polymerase chain reaction (PCR) method. The results were compared by using SPSS 16.0 and WINPEPI software's. The genotype distribution and allele frequency of the CCR5Δ32 were statistically different between the patients and the control group (P = 0.017; OR: 4.98 95% CI = 1.65-14.99 and P = 0.019; OR:4.76 95%CI = 1.30-17.50, respectively). CCR5/CCR5 (W/W) genotype and W allele of CCR5 gene were more common in patient group than in controls. There was no significant difference in severe and mild cases with regard to genotype distribution and allele distribution of CCR5Δ32 mutation (P >0.05). These results suggest that the CCR5 gene and its product might play a role in the pathogenesis of CCHF disease. Future studies will help us to uncover the exact role of CCR5 in the pathogenesis and prognosis of CCHF and to treat the disease.

摘要

克里米亚-刚果出血热感染(CCHF)是一种病毒性人畜共患病。该疾病的发病机制迄今尚未确定,但细胞因子与其进展和结局有关。本研究旨在探讨趋化因子受体 5(CCR5)基因Δ32 突变与 CCHF 的致病性、严重程度和死亡率之间的关系。这项病例对照研究包括 133 例通过检测 CCHV RNA 阳性而诊断的 CCHF 患者和 97 名健康对照者。采用聚合酶链反应(PCR)方法分析 CCR5 基因Δ32 突变。使用 SPSS 16.0 和 WINPEPI 软件进行比较。患者组和对照组的 CCR5Δ32 基因型分布和等位基因频率存在统计学差异(P=0.017;OR:4.98 95%CI=1.65-14.99 和 P=0.019;OR:4.76 95%CI=1.30-17.50)。CCR5/CCR5(W/W)基因型和 CCR5 基因的 W 等位基因在患者组中比在对照组中更为常见。在严重和轻度病例中,CCR5Δ32 突变的基因型分布和等位基因分布没有显著差异(P>0.05)。这些结果表明,CCR5 基因及其产物可能在 CCHF 发病机制中发挥作用。未来的研究将有助于揭示 CCR5 在 CCHF 发病机制和预后中的确切作用,并为该疾病的治疗提供帮助。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验